Skip to content
Search

Latest Stories

UKPPLAB to elevate pharmacist satisfaction and enhance patient safety

UKPPLAB to elevate pharmacist satisfaction and enhance patient safety
PDA advocates pharmacist autonomy in professional leadership amid CPhO influence

In a bid to bolster professional leadership within the pharmacy sector, the four government Chief Pharmaceutical Officers (CPhOs) have embarked on a significant initiative, forming the UK Pharmacy Professional Leadership Advisory Board (UKPPLAB).

In a recent communication, all pharmacists and pharmacy technicians received confirmation of the board members selected by the CPhOs, alongside a note from the board's appointed chair, who was chosen collectively by the four CPhOs and reports directly to the CPhO for England.


Over three years, the 21-member Board will implement recommendations from the UK Commission on Pharmacy Professional Leadership’s report aimed to enhance professional fulfillment among pharmacists while simultaneously augmenting patient safety standards.

This announcement also follows with the appointment of Sir Hugh Taylor as its Independent Chair and the appointment of Independent Expert Members who expressed his delight over the role's "potential to lead and support collaboration across the professions in the UK".

However, the move has been met with cautious optimism from the Pharmacists' Defence Association (PDA), urging the new board to uphold transparency and openness to garner trust among pharmacists.

The introduction of this government-backed initiative lies in the recommendations of a commission funded by the government, wherein the CPhOs played a pivotal role.

Serving as advisors, selectors, and recipients of the commission's final report, the CPhOs have now taken the reins in creating a leadership advisory board.

The composition of the UKPPLAB underscores the involvement of the CPhOs in selecting the board's chair, participating in interviews, and endorsing independent board members, whose remuneration will be facilitated by the NHS.

While acknowledging the stature of the four CPhOs within the NHS, the PDA emphasizes the need for pharmacists to have a decisive say in their professional leadership, separate from employer or governmental influence.

A critical point of contention raised by the PDA is related to transparency in the selection process and concerns have been voiced regarding the association of board members with specific organizations and the lack of clarity regarding their roles and affiliations.

The PDA advocates for full disclosure of interests, remuneration arrangements, and organizational affiliations of all board members to ensure transparency and accountability.

In light of these concerns, the PDA has also called for greater transparency, urging the publication of eligibility criteria, membership statistics, and funding sources for organizations represented on the board.

Additionally, individual board members are urged to declare their interests comprehensively to provide stakeholders with a clear understanding of the board's composition and potential influences underscoring the necessity for transparency and accountability in shaping the future of pharmacy practice in the UK.

More For You

 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less